SAN FRANCISCO and PARMA, ITALY — April 20, 2026 — Chiesi Group, an international biopharmaceutical group, has selected Salesforce’s Agentforce Life Sciences for Customer Engagement to transform its commercial operations and strengthen engagement with healthcare professionals worldwide.
Chiesi’s implementation of Agentforce Life Sciences marks a step-change in how it supports patients and healthcare professionals, bringing a more connected and responsive way of working across the organization. By moving to a unified platform, Chiesi is enabling its teams to act faster, collaborate more effectively, and focus on meaningful customer centric engagement. This innovation will empower employees with actionable insights, enhance interactions with healthcare professionals, and ultimately help build a more agile foundation for sustainable growth and deliver better outcomes for patients, while ensuring full compliance with pharmaceutical and privacy legislations as well as with responsible Artificial Intelligence standards.
Headquartered in Parma and now in its third generation of family leadership with more than 30 affiliates worldwide, Chiesi exports to more than 100 countries. A Benefit Corporation and a certified B Corp, Chiesi integrates business performance with social and environmental responsibility, embedding long-term value creation into its operating model. In 2024, the company reinvested 24% of its revenues into R&D — underscoring its strong innovation focus.
